Pasithea Therapeutics News

SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Nov 15 04:35

10-Q: Q3 2024 Earnings Report

Nov 14 05:37

EFFECT: Others

Oct 15 18:12

424B3: Prospectus

Oct 12 05:14

UPLOAD: Others

Oct 10 23:30

CORRESP: CORRESP

Oct 10 23:30

S-3: Registration statement for specified transactions by certain issuers

Oct 8 05:22

8-K: Current report

Oct 1 04:53

8-K: Current report

Sep 26 20:47

10-Q: Q2 2024 Earnings Report

Aug 14 04:36

8-K: Current report

Jun 27 05:04

4: Statement of changes in beneficial ownership of securities-Director Novak Alfred J

Jun 15 05:30

ARS: Annual Report to Security Holders

May 28 21:06

DEF 14A: Definitive information statements

May 28 21:01

8-K: Current report

May 15 05:20

10-Q: Q1 2024 Earnings Report

May 15 04:38

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Marques Tiago

Apr 6 09:49

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Dumesnil Simon

Apr 6 09:49

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Schneiderman Daniel H

Apr 6 09:49

Pasithea Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Leahy Emer

Apr 6 09:49